Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4

Clinical Cancer Research

Volumn 6, Issue 7, 2000, Pages 2618-2625

  Konety, Badrinath R ^a,b   Nguyen, Thu Suong T ^a,e   Dhir, Rajiv ^b   Day, Roger S ^a   Becich, Michael J ^b   Stadler, Walter M ^d   Getzenberg, Robert H ^b,c,d  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b Department of Urology ^*  (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR PROTEIN; PROTEIN BLCA 4; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS; TISSUE DISTRIBUTION;

ADULT; AGED; ANTIBODIES; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR PROTEINS; REFERENCE VALUES; TISSUE DONORS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0033911936     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Greenlee, R. T., Murray, T., Bolden, S., Wingo, P. A. Cancer Statistics 2000. CA Cancer J. Clin. 50: 7-33, 2000.
2. Case, R. A. M., Hosker, M. E., McDonald, D. B., and Pearson, J. T. Tumors of the urinary bladder in workmen engaged in the British chemical industry. Role of aniline, benzidine, α-naphtylamine and β-naphtylamine. Br. J. Indust. Med., 11: 75-104, 1954.
3. Kantor, A. F., Hartge, P., Hoover, R. N., Narayana, A., Sullivan, J. W., and Fraumeni, J. F., Jr. Urinary tract infections and the risk of bladder cancer. Am. J. Epidemiol., 119: 510-515, 1984.
4. Fradet, Y. Epidemiology of bladder cancer. In: N. J. Vogelzang, P. T. Scardino, W. U. Shipley, and D. S. Coffey (eds.), Comprehensive Textbook of Genitourinary Oncology, pp. 298-304. Baltimore: Williams and Wilkins, 1996.
5. Farrow, G. M. Urine cytology in the detection of bladder cancer: a critical approach. J. Occup. Med., 32: 817-821, 1990.
6. American Cancer Society. Cancer Facts and Figures: 1998. Washington, DC: American Cancer Society, 1998.
7. Pienta, K. J., Partin, A. W., and Coffey, D. S. Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res., 49: 2525-2532, 1989.
8. Getzenberg, R. H. The nuclear matrix and the regulation of gene expression: tissue specificity. J. Cell Biochem., 55: 22-31, 1994.
9. Berezney, R., and Coffey, D. S. Identification of a nuclear protein matrix. Biochem. Biophys. Res. Commun., 60: 1410-1417, 1974.
10. Fey, E. G., Bangs, P., Sparks, C., and Odgren, P. The nuclear matrix: defining structural and functional roles. Crit. Rev. Eukaryotic Gene Expression, 1: 127-144, 1991.
11. Getzenberg, R. H., and Coffey, D. S. Tissue specificity of the hormonal response in sex accessory is associated with nuclear matrix protein patterns. Mol. Endo., 4: 1336-1342, 1990.
12. Dworetzky, S. I., Fey, E. G., Penman, S., Lian, J. B., Stein, J. L., and Stein, G. S. Progressive changes in the protein composition of the nuclear matrix during rat osteoblast differentiation. Proc. Natl. Acad. Sci. USA, 87: 4605-4609, 1990.
13. Stuurman, N., van Driel, R., de Jong, L., Meijne, A. M. L., and van Renswoude, J. The protein composition of the nuclear matrix of murine P19 embryonal carcinoma cells is differentiation-state dependent. Exp. Cell Res., 180: 460-466, 1989.
14. Getzenberg, R. H., Pienta, K. J., Huang, E. Y. W., and Coffey, D. S. Identification of nuclear proteins in the cancer and normal rat prostate. Cancer Res., 51: 6514-6520, 1991.
15. Partin, A. W., Getzenberg, R. H., Carmichael, M. J., Vindivich, D., Yoo, J., Epstein, J. I., and Coffey, D. S. Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res., 53: 744-746, 1993.
16. Konety, B. R., Nangia, A. K., Nguyen, T-S. T., Veitmeier, B. N., Dhir, R., Aciemo, J. S., Becich, M. J., Hrebinko, R. L., and Getzenberg, R. H. Identification of nuclear matrix protein alterations associated with renal cell carcinoma. J. Urol., 159: 1359-1363, 1998.
17. Khanuja, P. S., Lehr, J. E., Soule, H. D., Gehani, S. K., Noto, A. C., Choudhury, S., Chen, R., and Pienta, K. J. Nuclear matrix proteins in normal and breast cancer cells. Cancer Res., 53: 3394-3398, 1993.
18. Keesee, S. K., Meneghini, M. D., Szaro, R. P., and Wu, Y. J. Nuclear matrix proteins in human colon cancer. Proc. Natl. Acad. Sci. USA, 91: 1913-1916, 1994.
19. Keesee, S. K., Meyer, J., Marchese, J., Oreper, A., Potz, D., St. Clair, J., and Wu, Y-J. A nuclear matrix protein marker for cervical dysplasia. Proc. Annu. Meet. Am. Assoc. Cancer Res., 39: 202, 1998.
20. Donat, T. L., Sakr, W., Lehr, J. E., and Pienta, K. J. Nuclear matrix protein alteration in intermediate biomarkers in squamous cell carcinoma of the head and neck. Otolaryngol. Head Neck Surgery, 127: 609-622, 1996.
21. McCaffrey, J. D., Gapany, M., Faust, R. A., Davis, A. T., Adams, G. L., and Ahmed, K. Nuclear matrix proteins as malignant markers in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg., 123: 283-288, 1997.
22. Soloway, M. S., Briggman, J. V., Caprinito, G. A., Chodak, G. W., Church, P. A., Lamm, D. L., Lange, P., Messing, E., Pasciak, R. M., Reservitz, G. B., Rukstalis, G. B., Sarosdy, M. F., Stadler, W. M., Thiel, R. P., and Hayden, C. L. Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J. Urol., 156: 363-367, 1996.
23. Getzenberg, R. H., Konety, B. R., Oeler, T. A., Quigley, M. M., Hakam, A., Becich, M. J., and Bahnson, R. R. Bladder cancer associated nuclear matrix proteins. Cancer Res., 56: 1690-1694, 1996.
24. Keesee, S. K., Briggman, J. V., Thill, G., Wu, Y. J. Utilization of nuclear matrix proteins for cancer diagnosis. CRC Crit. Rev. Eukaryotic Gene Expression, 6: 189-214, 1996.
25. Landman, J., Chang, Y., Kavalier, E., Droller, M. J., Liu, C-S. B. Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer. Urology, 52: 398-402, 1998.
26. Carpinito, G. A., Stadler, W. M., Briggman, J. V., Chodak, G. W., Church, P. A., Lamm, D. L., Lange, P. H., Messing, E. M., Pasciak, R. M., Reservitz, G. B., Ross, R. N., Rukstalis, D. B., Sarosdy, M. F., Soloway, M. S., Thiel, R. P., Vogelzang, N., and Hayden, C. L. Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract. J. Urol., 156: 1280-1285, 1996.
27. Miyanaga, N., Akaza, H., Ishikawa, S., Ohtani, M., Noguchi, R., Kawai, K., Koise, K., Kobayashi, M., Koyama, A., and Takahashi, T. Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer. Eur. Urol., 31: 163-168, 1997.